Articles Archives
Articles
10/26/2026
Cryoport Systems Welcomes Chris LaGullo as Chief Operations Officer
As advanced therapies become more complex and move closer to broader commercial adoption, life sciences organizations are navigating increasingly sophisticated supply chains. From maintaining product integrity across global networks to navigating evolving regulatory requirements, success depends on a supply chain partner capable of delivering consistent, reliable operational execution across the product lifecycle. To continue supporting evolving industry needs, Cryoport Systems is pleased to welcome Chris LaGullo as Chief Operating Officer.
Articles
10/23/2026
Prioritizing Commercialization Decisions in Early Stages of Advanced Therapy Development
Successful biopharmaceutical organizations begin developing a commercialization strategy in early stages. Instead of waiting until their advanced therapy or biologics product is closer to pivotal trial stages, developers should confront these decisions as soon as possible. In a recent interview with Pharmaceutical Commerce, Gwen Erskine, Senior Director of Consulting Services at Cryoport Systems, illustrates why prioritizing commercialization readiness during early phases of development optimizes profitability, flexibility, and risk management.
Articles
09/21/2026
Cryoport Systems Wins Healthcare & Pharmaceutical Supply Chain Excellence Award for Advancing Patient Safety Through ISO 21973-Certified Supply Chain
Cryoport Systems is proud to announce that it has received the Healthcare & Pharmaceutical Supply Chain Excellence Award at the 2026 Supply Chain Excellence USA Awards. Part of a globally recognized awards program with a nearly 30-year legacy, the Supply Chain Excellence Awards recognize organizations that demonstrate innovation, collaboration, and measurable impact through supply chain excellence.
Articles
09/08/2026
Cryoport Systems Welcomes Robin Grimwood as Chief Commercial Officer
Robin Grimwood has joined Cryoport Systems as the company’s new Chief Commercial Officer. Robin brings more than three decades of leadership experience in the global life sciences industry, with a proven track record of building, scaling, and transforming businesses across clinical services, genomics, biorepositories, laboratory automation, and sample management. Robin will lead the company’s continued growth and help strengthen its ability to serve the evolving needs of clients around the world.
Articles
09/02/2026
Building the Infrastructure to Enable Patient Access to Advanced Therapies: A Deep-Dive with Dominic Clarke, VP of Technical Operations
Advanced therapies have delivered some of the most significant medical breakthroughs of our time and fundamentally changed patient outcomes. The science is proven, but innovation alone doesn't guarantee patient access. In a recent interview with Drug Delivery Leader, Dominic Clarke, VP of Technical Operations at Cryoport Systems, dives into supply chain challenges, advances in technology, and how to build best-in-class processes for scalability, enabling life-changing therapies to reach the patients who need them.
Articles
08/28/2026
Continuing the Conversation: What Quality Leaders Need to Know About Building Supply Chains for Advanced Therapies
Following Pharmaceutical Commerce’s podcast with Adam Fox, Chief Quality & Regulatory Affairs Officer at Cryoport Systems, we wanted to explore several topics that deserve a deeper look. As cell and gene therapies continue to advance, quality leaders are discovering that supply chains have become an extension of the quality system itself.
Articles
08/18/2026
Beyond Clinical Success: Bianca Gustafson on Building Supply Chains That Scale
In a recent Contract Pharma interview, Bianca Gustafson, Senior Director of Program Management at Cryoport Systems, shared an important perspective on the transition from clinical development to commercialization. According to Gustafson, a common mistake organizations make is assuming that commercial readiness is an extension of clinical operations, when actually commercialization requires a full-on shift in how supply chains are designed and scaled.
Articles
08/17/2026
Cryoport Systems Officially Opens New Global Supply Chain Center in Santa Ana, California
Cryoport Systems, a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the official opening of its new Global Supply Chain Center (GSCC) in Santa Ana, California. The 86,500-square-foot facility strengthens global logistics infrastructure and establishes a foundation for future growth.
Articles
07/21/2026